Acorn Financial Advisory Services Inc Bristol Myers Squibb CO Transaction History

Acorn Financial Advisory Services Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$59.17 - $69.31 $344,606 - $403,661	-5,824 Closed	0 $0
Q2 2021 Jul 23, 2021	BUY	$61.91 - $67.42 $6,191 - $6,742	100 Added 1.75%	5,824 $390,000
Q1 2021 Apr 12, 2021	BUY	$59.34 - $66.74 $59 - $66	1 Added 0.02%	5,724 $358,000
Q4 2020 Jan 25, 2021	BUY	$57.74 - $65.43 $1,674 - $1,897	29 Added 0.51%	5,723 $357,000
Q3 2020 Oct 15, 2020	BUY	$57.43 - $63.64 $7,236 - $8,018	126 Added 2.26%	5,694 $344,000
Q2 2020 Jul 10, 2020	SELL	$54.82 - $64.09 $8,223 - $9,613	-150 Reduced 2.62%	5,568 $328,000
Q4 2019 Jan 27, 2020	BUY	$49.21 - $64.19 $281,382 - $367,038	5,718 New	5,718 $368,000

2,533

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $125B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Acorn Financial Advisory Services Inc , based on Form 13F filings with the SEC.

Stay updated on Acorn Financial Advisory Services Inc with notifications on news.